Comparison of orally exhaled nitric oxide in allergic versus nonallergic rhinitis

American Journal of Rhinology and Allergy

Volumn 26, Issue 2, 2012, Pages

  Kalpaklioglu, A Fusun ^a   Kalkan, Ilkay K ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FRACTIONAL EXHALED NITRIC OXIDE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXHALED NITRIC OXIDE LEVEL; EXPIRED AIR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; PRURITUS; QUALITY OF LIFE; RHINORRHEA; SEASONAL VARIATION; SNEEZING; VASOMOTOR RHINITIS;

ADULT; ANIMALS; ASTHMA; BREATH TESTS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS; SPIROMETRY; YOUNG ADULT;

EID: 84860182264     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2012.26.3717     Document Type: Article

References (36)

1. Rolla G, Guida G, Heffler E, et al. Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma. A clinical study of a consecutive series of patients. Chest 131:1345-1352, 2007. (Pubitemid 46762338)
2. Chiron R, Vachier I, Khanbabaee G, et al. Impact of rhinitis on asthma control in children: Association with FeNO. J Asthma 47:604-608, 2010.
3. Chawes BLK, Bønnelykke K, Kreiner-Møller E, et al. Children with allergic and nonallergic rhinitis have a similar risk of asthma. J Allergy Clin Immunol 126:567-573, 2010.
4. Kim SH, Kim TH, Sohn JW, et al. Reference values and determinants of exhaled nitric oxide in healthy Korean adults. J Asthma 47:563-567, 2010.
5. Bakkeheim E, Mowinckel P, von Carlsen KH, et al. Altered oxidative state in school children with asthma and allergic rhinitis. Pediatr Allergy Immunol 22:178-185, 2011.
6. Corderio D, Rudolphus A, Snoey E, et al. Utility of nitric oxide for the diagnosis of asthma in an allergy clinic population. Allergy Asthma Proc 32:119-126, 2011.
7. Perdoletti C, Lundahl J, Alving K, et al. Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic school children with perennial rhinitis and asthma. Pediatr Allergy Immunol 19:219-226, 2008. (Pubitemid 351499166)
8. Makinen T, Lehtimaki L, Kinnunen H, et al. Bronchial diffusing capacity of nitric oxide is increased in patients with allergic rhinitis. Int Arch Allergy Immunol 148:154-160, 2009.
9. Tufvesson E, Aronsson D, Ankerst J, et al. Peripheral nitric oxide is increased in rhinitic patients with asthma compared to bronchial hyperresponsiveness. Respir Med 101:2321-2326, 2007. (Pubitemid 47471401)
10. Bousquet J, Khaltaev N, Cruz AA, et al.; World Health Organization; GA(2)LEN; and AllerGen. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
11. Silkoff PE, Carlson M, Bourke T, et al. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol 114:1241-1256, 2004. (Pubitemid 39469172)
12. Ragab A, Clement P, and Vincken W. Objective assessment of lower airway involvement in chronic rhinosinusitis. Am J Rhinol 18:15-21, 2004. (Pubitemid 38351409)
13. Kharitonov SA, Yates D, and Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 8:295-297, 1995.
14. Jouaville LF, Annesi-Maesano I, Nguyen LT, et al. Interrelationships among asthma, atopy, rhinitis and exhaled nitric oxide in a population-based sample of children. Clin Exp Allergy 33:1506-1511, 2003. (Pubitemid 37421627)
15. Aronsson D, Tufvesson E, and Bjermer L. Allergic rhinitis with or without concomitant asthma: Difference in perception of dyspnoea and levels of fractional exhaled nitric oxide. Clin Exp Allergy 35:1457-1461, 2005.
16. Ciprandi G, Tosca MA, and Capasso M. Exhaled nitric oxide in children with allergic rhinitis and/or asthma: A relationship with bronchial hyperreactivity. J Asthma 47:1142-1147, 2010.
17. Scadding G, and Scadding GK. Update on the use of nitric oxide as a noninvasive measure of airways inflammation. Rhinology 47:115-120, 2009.
18. Giannessi F, Fattori B, Ursino F, et al. Ultrastructural and ultracytochemical study of the human nasal respiratory epithelium in vasomotor rhinitis. Acta Otolaryngol 123:943-949, 2003. (Pubitemid 37346553)
19. Kalpaklioglu AF, and Kavut AB. Allergic and nonallergic rhinitis: Can we find the differences/similarities between the two pictures? J Asthma 46:481-485, 2009.
20. Yuksel H, Kirmaz C, Yilmaz O, et al. Nasal mucosal expression of nitric oxide synthases in patients with allergic rhinitis and its relation to asthma. Ann Allergy Asthma Immunol 100:12-16, 2008.
21. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 171:912-930, 2005.
22. Travers J, Marsh S, Aldington S, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 176:238-242, 2007. (Pubitemid 47195873)
23. Dressel H, de la Motte D, Reichert J, et al. Exhaled nitric oxide: Independent effects of atopy, smoking, respiratory tract infection, gender and height. Respir Med 108:962-969, 2008.
24. Olin AC, Rosengren A, Thelle DS, et al. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 130:1319-1325, 2006. (Pubitemid 44786722)
25. Olivieri M, Talamini G, Corradi M, et al. Reference values for exhaled nitric oxide (reveno) study. Respir Res 7:94, 2006.
26. Bergmann-Hugg K, Wirth R, Henseler M, et al. Effect of natural pollen exposure and repeated nasal allergen provocation on elevation of exhaled nitric oxide. Allergy 64:1629-1634, 2009.
27. Lopuhaä CE, Koopmans JG, Jansen HM, et al. Similar levels of nitric oxide in exhaled air in non-asthmatic rhinitis and asthma after bronchial allergen challenge. Allergy 58:300-305, 2003. (Pubitemid 36566747)
28. Henriksen AH, Sue-Chu M, Holmen TL, et al. Exhaled and nasal NO levels in allergic rhinitis: Relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J 13:301-306, 1999. (Pubitemid 29086824)
29. Sandrini A, Ferreira IM, Jardim JR, et al. Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol 111:313-320, 2003. (Pubitemid 36228552)
30. Ohkura N, Fujimura M, Tokuda A, et al. Evaluation of airway hiperresponsiveness and exhaled nitric oxide as risk factors for airway remodeling in patients with stable asthma. Allergy Asthma Proc 30:419-423, 2009.
31. Burkstein D, Luskin AT, and Brooks EA. Exhaled nitric oxide as a tool in managing and monitoring difficult-to-treat asthma. Allergy Asthma Proc 32:185-192, 2011.
32. Sippel JM, Holden WE, Tilles SA, et al. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol 106:645-650, 2000.
33. Gelfand EW. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 114:S135-S138, 2004. (Pubitemid 39440924)
34. Michils A, Baldassarre S, and Van Muylem A. Exhaled nitric oxide and asthma control: A longitudinal study in unselected patients. Eur Respir J 31:539-546, 2008.
35. Roberts G, Mylonopoulou M, Hurley C, et al. Impairment in quality of life is directly related to the level of allergen exposure and allergic airway inflammation. Clin Exp Allergy 35:1295-1300, 2005.
36. Quaedvlieg V, Sele J, Henket M, et al. Association between asthma control and bronchial hyperresponsiveness and airways inflammation: A cross-sectional study in daily practice. Clin Exp Allergy 39:1822-1829, 2009.